Technology ID
TAB-3290

Edema Factor Adenylate Cyclase Variants Having Potencies That Are Highly Dependent On the N-end Rule

E-Numbers
E-737-2013-0
Lead Inventor
Leppla, Stephen (NIAID)
Co-Inventors
Leysath, Clinton (The Texas A&M University System)
Applications
Research Materials
Therapeutic Areas
Infectious Disease
Lead IC
NIAID
ICs
NIAID
B. anthracis strains BH480; plasmids encoding anthrax edema factor (EF) variants pSJ136EFOS, pSJ 136EFA and pSJ 136EFR.
Commercial Applications
  • A research material that can be used in the development of assays, validation of products or in quality control.
Competitive Advantages
  • Speed up product development with NIH developed material that has already been tested and validated.

Request More Info

Licensing Contact:
Green, Wade
wade.green@nih.gov

Publications

  • Leysath CR, et al.
  • This record was updated as part of a batch update by the OTT team. The Owner of this record was updated from ‘Admin’ to the Licensing Contact listed on the record on 7/25/2024. If you have any questions or concerns, please reach out to ETT Support.

Collaborations

  • Licensing
Date Published